BACKGROUND
The diagnosis of papillary thyroid microcarcinoma (thyroid cancer smaller than 1cm in size) has increased because of increased detection by medical imaging (often for non-thyroid related reasons). Papillary thyroid microcarcinoma is generally managed with less extensive surgery than larger thyroid cancers since it rarely spreads to the lymph nodes outside the neck. This means that often only the lobe containing the thyroid cancer is removed (thyroid lobectomy). Overall, patients with papillary thyroid microcarcinoma are considered to be at low risk for cancer recurrence after surgery.
However, despite the excellent prognosis, some patients still have lymph nodes under and behind the thyroid removed routinely even if they do not look abnormal on visual inspection at the time of surgery (a prophylactic central neck dissection). This study investigated the benefit of prophylactic central neck dissection to decrease recurrence of thyroid cancer in the neck in patients with papillary thyroid microcarcinoma who underwent thyroid lobectomy.
THE FULL ARTICLE TITLE
Ryu YJ and Yoon JH 2020 Impact of prophylactic unilateral central neck dissection needed for patients with papillary thyroid microcarcinoma. Gland Surg 9:352–361. PMID: 32420259.
SUMMARY OF THE STUDY
This was a medical chart review of > 5000 patients who underwent a thyroid lobectomy for papillary thyroid microcarcinoma from 2004-2012 at hospital with extensive thyroid cancer management experience. Of those charts reviewed, 1071 patients were studied who did not have evidence of cancer spread to the lymph nodes prior to surgery. Patients were excluded if they were followed up for <1 year, had experienced thyroid cancer recurrence within 6 months, had thyroid pathology other than classical papillary thyroid carcinoma, had known nodules in the remaining thyroid lobe, or had abnormal serum thyroid function test results. Cancer recurrence was defined as the presence of abnormal lymph nodes on neck ultrasound. All recurrences were confirmed by fine needle biopsy that showed papillary thyroid cancer. Case follow up was for an average of almost 7 years.